Drugs / KBP-V001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04439695 | Jun 2020 → Feb 2021 | influenza | KBio Inc | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KBP-V001 | “Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults” NCT04439695 ↗ |
| Modality | Vaccine | “KBP-V001 Quadrivalent Influenza Vaccine” NCT04439695 ↗ |
| Route | Intramuscular | “by intramuscular (IM) injection” NCT04439695 ↗ |